Study offers better insights into quality of life for adults with congenital heart disease Washington, D.C., Oct. 16, 2024 (GLOBE NEWSWIRE) -- For the first time, adults living with congenital heart disease (CHD) now have valuable insights into their long-term quality of life through data...

Eyenuk Announces Publication of Strong EyeArt® Pivotal Clinical Trial Results in JAMA Network Open LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye...